NSCLC patients with PD-L1 high expression are more likely to be male, over 65 years old, LUSC, smoker, tumor maximum diameter >3 cm, poor differentiation, T1–T3 stage, regional lymph node metastasis, tumor metastasis or clinical stages III–IV. This evidence concerns the gene CD274 and non-small cell lung carcinoma.